Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-18-140977
Filing Date
2018-04-30
Accepted
2018-04-30 08:32:04
Documents
10
Period of Report
2018-06-18
Effectiveness Date
2018-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d546548ddef14a.htm DEF 14A 558228
2 GRAPHIC g546548newpc1f.jpg GRAPHIC 22452
3 GRAPHIC g546548pc1.jpg GRAPHIC 50011
4 GRAPHIC g546548pc1a.jpg GRAPHIC 44085
5 GRAPHIC g546548pc1b.jpg GRAPHIC 9015
6 GRAPHIC g546548pc1c.jpg GRAPHIC 16402
7 GRAPHIC g546548pc1d.jpg GRAPHIC 1425
8 GRAPHIC g546548pc1e.jpg GRAPHIC 1518
9 GRAPHIC g546548pc1g.jpg GRAPHIC 1363
10 GRAPHIC g546548prr.jpg GRAPHIC 860
  Complete submission text file 0001193125-18-140977.txt   757976
Mailing Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33221 | Film No.: 18786812
SIC: 2834 Pharmaceutical Preparations